LINDSEY THOMAS: Open Payments
NPI 1245765007 · NEWHALL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 22 payments from 11 companies in 2025. Trend: 2023 $31 · 2024 $715 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 5 | $76 |
| ABBVIE INC. | 3 | $57 |
| PFIZER INC. | 3 | $55 |
| Boston Scientific Corporation | 2 | $48 |
| Globus Medical, Inc. | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| TerSera Therapeutics LLC | 1 | $32 |
| Virtus Pharmaceuticals LLC | 1 | $16 |
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 1 | $15 |
| Valinor Pharma, LLC | 1 | $15 |
Products named: Belbuca, NURTEC ODT, WaveWriter Alpha Prime 16, QULIPTA, RELISTOR, Prialt, Vyrsa V1, Senza.
Industry payments across CA — which companies pay providers there.
